SEARCH RESULT

Total Matching Records found : 3511

Ramesh Chand, member of NITI Aayog and eminent agriculture economist, speaks to Sanjeeb Mukherjee

-Business Standard India’s growth in agriculture and allied activities has struggled to reach the targeted four per cent average a year in the first three years of the 12th five-year Plan because of a host of factors. The below-average farm growth is widely expected to deepen the crisis in the farm sector. In an interview with Sanjeeb Mukherjee, newly-appointed member of NITI Aayog and eminent agriculture economist Ramesh Chand  said over-reliance...

More »

SC dismisses PIL challenging Aadhaar card requirement for DigiLocker scheme -Shreeja Sen

-Livemint.com SC refused to entertain a PIL challenging the requirement of Aadhaar card number for the DigiLocker scheme introduced by the govt earlier New Delhi: The Supreme Court on Monday refused to entertain a Public Interest litigation (PIL) challenging the mandatory requirement of Aadhaar card number for the DigiLocker scheme introduced by the government earlier. The petitioner had filed a writ petition in the light of three apex court orders which said...

More »

A flawed agenda for development -Ashish Kothari

-The Hindu Business Line A narrow focus on growth-led development is the cause of the world’s sustainability crisis, not its solution The world’s political leaders meet in New York today to adopt a ‘sustainable development’ agenda. On the face of it, this sounds very hopeful. It signals that finally, humanity may move towards making peace with the earth, even as it erases the shame of over two billion people still living in...

More »

Lie of the land: Only 39 of 133 GM crop field trials monitored in 6 years -Dipu Rai

-DNA The Centre has always claimed that the country has a robust regulatory mechanism Busting the claims of the Indian government and scientists that the country has a robust regulatory mechanism to test genetically modified (GM) crops, toxic loopholes are emerging. From 2008 to 2014, only 39 of the 133 GM crop field trials were properly monitored, leaving the rest for unknown risks and possible health hazards to common people. Documents accessed...

More »

Soon, cancer medicines, stents to be cheaper -Sushmi Dey

-The Times of India NEW DELHI: Cancer medicines and stents may soon be available at a substantially lower price. The health ministry is working on a model to procure such drugs in bulk at a negotiated price and supply them to hospitals and consumers through its own retail system like 'Jan Aushadhi' stores. . The idea is to bring down prices of expensive cancer drugs and stents while not putting pressure on...

More »

Video Archives

Archives

share on Facebook
Twitter
RSS
Feedback
Read Later

Contact Form

Please enter security code
      Close